Literature DB >> 2497093

Variation in tumor response to fluosol-DA (20%).

K Sasai1, K Ono, T Nishidai, K Tsutsui, Y Shibamoto, M Takahashi, M Abe.   

Abstract

The effects of Fluosol-DA 20% (FDA) and carbogen (95% O2/5% CO2) on radiosensitivity of the three experimental tumors, SCC VII tumor, RIF-I tumor, and transplanted mammary tumor of C3H/He mouse, subcutaneously inoculated in the leg were examined. The effect of FDA plus carbogen, and carbogen alone on radiosensitivity of SCC VII and RIF-I tumors was tested using the in vivo-in vitro assay. The growth curves were obtained for both SCC VII tumor and transplanted mammary tumor. The effect of the combination of FDA and carbogen was only observed in the transplanted mammary tumor. In the other two tumors, only the effect of inspiring carbogen was observed. We concluded that the effect of FDA on the radiosensitivity of experimental tumors varies with the kind of tumor systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497093     DOI: 10.1016/0360-3016(89)90271-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.

Authors:  K Sasai; Y Shibamoto; M Takahashi; L Zhou; H Hori; H Nagasawa; T Shibata; S Inayama; M Abe
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.

Authors:  D J Chaplin; M R Horsman; D W Siemann
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

3.  A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.

Authors:  K Sasai; Y Shibamoto; M Takahashi; M Abe; J Wang; L Zhou; S Nishimoto; T Kagiya
Journal:  Jpn J Cancer Res       Date:  1989-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.